Opportunities Preloader

Please Wait.....

Report

Global Prenatal Testing Market

Market Research Report I 2024-04-24 I 134 Pages I BCC Research

Description

Report Scope
The scope of the prenatal testing market is extensive and continually evolving, reflecting the dynamic landscape of technologies and methodologies employed to assess fetal health during pregnancy. Genetic testing plays a central role, encompassing a range of approaches from traditional invasive procedures, such as amniocentesis and chorionic villus sampling to modern noninvasive methods, such as noninvasive prenatal testing (NIPT). This market is characterized by its global reach, with varying levels of adoption and accessibility across different regions. The focus is predominantly on screening for genetic disorders, including chromosomal abnormalities and hereditary conditions. The rise of comprehensive testing strategies evaluating multiple biomarkers enhances diagnostic accuracy. The market is driven by increasing maternal age, heightened awareness of genetic disorders and technological advancements. Ongoing research and development (R&D) efforts continue to shape the scope of prenatal testing, with a strong emphasis on improving accuracy and accessibility and incorporating innovative diagnostic and screening procedures. It presents insights into current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this helpful study.
Report Includes
- 37 data tables and 52 additional tables
- An overview of the current and future global markets for prenatal testing
- Analyses of global market trends, with historical revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
- Estimates of the current market size and revenue growth prospects, along with a market share analysis by technology and product types, application, end users and region
- Discussion of the market opportunities and challenges, ongoing R&D efforts and regulatory scenarios
- A look at emerging technologies related to prenatal testing
- Overview of the sustainability trends and ESG developments, with emphasis on consumer attitudes, companies' ESG rankings and their ESG practices
- Insight into the competitive landscape, including company market shares, financials and revenues
- Profiles of the leading players, including Illumina Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Natera Inc., and F. Hoffmann-La Roche Ltd.

Executive Summary

Summary:
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Prenatal Testing
History of Prenatal Testing
Most Common Chromosomal Abnormalities
Down Syndrome
Trisomy 13 and Trisomy 18
Sex Chromosome Differences
Neural Tube Defects
Noninvasive Techniques
Noninvasive Prenatal Test/Cell-Free DNA Screening
Maternal Serum Screening Test
Ultrasound Testing
Others
Invasive Techniques
Chorionic Villus Sampling
Amniocentesis
Chapter 3 Market Dynamics
Factors Affecting the Prenatal Testing Market
Market Drivers
Increase in Down Syndrome
Increase in Rare Genetic Disorders
Increasing Maternal Age
Advancements in Technology
Restraints
High Cost of Testing
False Positives and Negatives Results
Future Opportunities
Expanding Applications
Emerging Markets
Personalized Medicine
Challenges
Regulatory Hurdles
Public Perception
Noninvasive Prenatal Testing Coverage Challenges: Policy Disparities
Chapter 4 Emerging and Upcoming Technologies in the Market
Introduction
Enhancing Copy Number Variation Detection Through Whole-Genome Sequencing
Single Nucleotide Polymorphisms Analysis
Whole-Exome Sequencing
Advanced Imaging Techniques
Liquid Biopsy for Cancer Detection
Artificial Intelligence in Prenatal Testing
Chapter 5 Market Segmentation Analysis
Segmentation by Product Type
Market Size
Consumables
Instruments
Segmentation by Technology
Overview
Market Share
Noninvasive Techniques
Invasive Techniques
Segmentation by Application
Overview
Market Share
Neural Tube Defects
Down Syndrome
Rare Genetic Disorders
Others
Segmentation by End User
Overview
Market Share
Diagnostic Laboratories
Hospitals
Geographic Breakdown
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Landscape
Mergers, Acquisitions and Collaborations
Prenatal Testing Manufacturers and Service Providers Market Shares
Patent Review and New Developments
Overview
Patent Analysis by Year
Chapter 7 ESG Development
Introduction
Sustainability of Prenatal Testing in Industry
BCC Research Viewpoint
Chapter 8 Appendix
Methodology
Intended Audience
Abbreviations
Sources
Company Profiles
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BGI
EUROFINS SCIENTIFIC
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDICOVER GENETICS
NATERA INC.
QIAGEN
QUEST DIAGNOSTICS INC.
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.
YOURGENE HEALTH

List of Tables
Summary Table : Global Prenatal Testing Market, by Product, Through 2028
Table 1 : Timeline of Technology Development of Prenatal Testing, 1956-2017
Table 2 : Chance for Down Syndrome, by Age
Table 3 : Price Per Prenatal Testing Strategy, 2021
Table 4 : Global Prenatal Testing Market, by Product, Through 2028
Table 5 : Global Consumables Products Market in Prenatal Testing, by Region, Through 2028
Table 6 : Global Instruments Products Market in Prenatal Testing, by Region, Through 2028
Table 7 : Global Prenatal Testing Market, by Technology, Through 2028
Table 8 : Global Noninvasive Techniques Market in Prenatal Testing, by Type, Through 2028
Table 9 : Global Noninvasive Prenatal Testing Market, by Region, Through 2028
Table 10 : Global Maternal Serum Screening Market, by Region, Through 2028
Table 11 : Global Ultrasound-Based Testing Market, by Region, Through 2028
Table 12 : Global Others Noninvasive Techniques Market, by Region, Through 2028
Table 13 : Global Invasive Techniques in Prenatal Testing Market, by Type, Through 2028
Table 14 : Global Amniocentesis Invasive Techniques Market, by Region, Through 2028
Table 15 : Global Chorionic Villus Sampling Invasive Techniques Market, by Region, Through 2028
Table 16 : Global Others Invasive Techniques Market, by Region, Through 2028
Table 17 : Global Prenatal Testing Market, by Application, Through 2028
Table 18 : Global Neural Tube Defects Market in Prenatal Testing, by Region, Through 2028
Table 19 : Global Down Syndrome Market in Prenatal Testing, by Region, Through 2028
Table 20 : Global Rare Genetic Disorders Market in Prenatal Testing, by Region, Through 2028
Table 21 : Global Other Application Market in Prenatal Testing, by Region, Through 2028
Table 22 : Global Prenatal Testing Market, by End User, Through 2028
Table 23 : Global Prenatal Testing Market in Diagnostic Laboratories, by Region, Through 2028
Table 24 : Global Prenatal Testing Market in Hospitals, by Region, Through 2028
Table 25 : Global Prenatal Testing Market, by Region, Through 2028
Table 26 : North American Prenatal Testing Market, by Country, Through 2028
Table 27 : European Prenatal Testing Market, by Country, Through 2028
Table 28 : Asia-Pacific Prenatal Testing Market, by Country, Through 2028
Table 29 : Mergers and Acquisitions: Prenatal Testing Manufacturers and Service Providers
Table 30 : Patent Analysis, by Year, 2020-August 2023
Table 31 : Major Patents in Prenatal Testing, by Applicant, 2023-February 2024
Table 32 : ESG Highlights, by Major Players, 2022
Table 33 : ESG Rankings of Major Companies Manufacturing Prenatal Testing, 2023
Table 34 : Abbreviations
Table 35 : Report Sources
Table 36 : 10X Genomics: Company Snapshot
Table 37 : 10X Genomics: Financial Performance, FY 2022 and 2023
Table 38 : 10X Genomics: Product Portfolio
Table 39 : 10X Genomics: News and Key Developments, 2023
Table 40 : Agilent Technologies Inc.: Company Snapshot
Table 41 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 42 : Agilent Technologies Inc.: Product Portfolio
Table 43 : Agilent Technologies Inc.: News and Key Developments, 2020-2023
Table 44 : BGI: Company Snapshot
Table 45 : BGI Genomics: Product Portfolio
Table 46 : BGI Genomics: News and Key Developments, 2023 and 2024
Table 47 : Eurofins Scientific: Company Snapshot
Table 48 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 49 : Eurofins Scientific: Product Portfolio
Table 50 : Eurofins Scientific: News and Key Developments, 2022
Table 51 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 52 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 53 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 54 : F. Hoffmann-La Roche Ltd.: News and Key Developments, 2022 and 2023
Table 55 : Illumina Inc.: Company Snapshot
Table 56 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 57 : Illumina Inc.: Product Portfolio
Table 58 : Illumina Inc.: News and Key Developments, 2022-2024
Table 59 : Laboratory Corporation of America Holdings: Company Snapshot
Table 60 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 61 : Laboratory Corporation of America Holdings: Product Portfolio
Table 62 : Laboratory Corporation of America Holdings: News and Key Developments, 2022-2024
Table 63 : Medicover Genetics: Company Snapshot
Table 64 : Medicover Genetics: Product Portfolio
Table 65 : Medicover Genetics: News and Key Developments, 2022 and 2023
Table 66 : Natera Inc.: Company Snapshot
Table 67 : Natera Inc.: Financial Performance, FY 2021 and 2022
Table 68 : Natera Inc.: Product Portfolio
Table 69 : Natera Inc.: News and Key Developments, 2024
Table 70 : Qiagen: Company Snapshot
Table 71 : QIAGEN: Annual Financials/Revenue, 2021 and 2022
Table 72 : Qiagen: Product Portfolio
Table 73 : Qiagen: News and Key Developments, 2022-2024
Table 74 : Quest Diagnostic Inc.: Company Snapshot
Table 75 : Quest Diagnostic Inc.: Financial Performance, FY 2022 and 2023
Table 76 : Quest Diagnostic Inc.: Product Portfolio
Table 77 : Quest Diagnostic Inc.: News and Key Developments, 2021-2024
Table 78 : Revvity Inc.: Company Snapshot
Table 79 : Revvity Inc.: Financial Performance, FY 2021 and 2022
Table 80 : Revvity Inc.: Product Portfolio
Table 81 : Revvity Inc.: News and Key Developments, 2021-2023
Table 82 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 83 : Thermo Fisher Scientific Inc.: Annual Financials/Revenue, 2021 and 2022
Table 84 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 85 : Thermo Fisher Scientific Inc.: News and Key Developments, 2022 and 2023
Table 86 : Yourgene Health: Company Snapshot
Table 87 : Yourgene Health Product Portfolio
Table 88 : Yourgene Health News/Key Developments, 2022 and 2023

List of Figures
Summary Figure : Global Prenatal Testing Market, by Product, 2020-2028
Figure 1 : Down Syndrome Karyotype
Figure 2 : Market Dynamics: Global Prenatal Testing Market
Figure 3 : Universal NIPT Coverage Across Payer Networks, 2020
Figure 4 : Global Prenatal Testing Market, by Segment Analysis
Figure 5 : Global Prenatal Testing Market, by Product, 2020-2028
Figure 6 : Global Consumables Products Market in Prenatal Testing, by Region, 2020-2028
Figure 7 : Global Instruments Products Market in Prenatal Testing, by Region, 2020-2028
Figure 8 : Global Prenatal Testing Market, by Technology, 2020-2028
Figure 9 : Global Noninvasive Techniques Market in Prenatal Testing, by Type, 2020-2028
Figure 10 : Global Noninvasive Prenatal Testing Market, by Region, 2020-2028
Figure 11 : Global Maternal Serum Screening Market, by Region, 2020-2028
Figure 12 : Global Ultrasound-Based Testing Market, by Region, 2020-2028
Figure 13 : Global Others Noninvasive Techniques Market, by Region, 2020-2028
Figure 14 : Global Invasive Techniques in Prenatal Testing Market, by Type, 2020-2028
Figure 15 : Global Amniocentesis Invasive Techniques Market, by Region, 2020-2028
Figure 16 : Global Chorionic Villus Sampling Invasive Techniques Market, by Region, 2020-2028
Figure 17 : Global Others Invasive Techniques Market, by Region, 2020-2028
Figure 18 : Global Prenatal Testing Market, by Application, 2020-2028
Figure 19 : Global Neural Tube Defects Market in Prenatal Testing, by Region, 2020-2028
Figure 20 : Global Down Syndrome Market in Prenatal Testing, by Region, 2020-2028
Figure 21 : Global Rare Genetic Disorders Market in Prenatal Testing, by Region, 2020-2028
Figure 22 : Global Other Application Market in Prenatal Testing, by Region, 2020-2028
Figure 23 : Global Prenatal Testing Market, by End User, 2020-2028
Figure 24 : Global Prenatal Testing Market in Diagnostic Laboratories, by Region, 2020-2028
Figure 25 : Global Prenatal Testing Market, in Hospitals, by Region, 2020-2028
Figure 26 : Global Prenatal Testing Market, by Region, 2020-2028
Figure 27 : Global Prenatal Testing Market Share, by Region, 2022
Figure 28 : North American Prenatal Testing Market, by Country, 2020-2028
Figure 29 : European Prenatal Testing Market, by Country, 2020-2028
Figure 30 : Asia-Pacific Prenatal Testing Market, by Country, 2020-2028
Figure 31 : Global Prenatal Testing Market Shares, by Key Manufacturers and Service Providers 2022
Figure 32 : Published Patent Share, by Country, 2020-2023
Figure 33 : Business Benefits of a Strong ESG Proposition
Figure 34 : ESG-Adoption Level Across All the Industries, 2021 and 2022
Figure 35 : 10 Business Sustainability Trends Identified for 2023
Figure 36 : 10X Genomics: Revenue Share, by Business Unit, FY 2023
Figure 37 : 10X Genomics: Revenue Share, by Country/Region, FY 2023
Figure 38 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
Figure 41 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Illumina Inc.: Revenue Share, by Business Unit, FY 2022
Figure 44 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023
Figure 46 : Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023
Figure 47 : Natera Inc.: Revenue Share, by Business Unit, FY 2022
Figure 48 : Natera Inc.: Revenue Share, by Country/Region, FY 2022
Figure 49 : Qiagen: Revenue Share, by Business Unit, 2022
Figure 50 : Qiagen: Revenue Share, by Region, 2022
Figure 51 : Quest Diagnostic Inc.: Revenue Share, by Business Unit, FY 2023
Figure 52 : Revvity Inc.: Revenue Share, by Business Unit, FY 2022
Figure 53 : Revvity Inc.: Revenue Share, by Country/Region, FY 2022
Figure 54 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2022
Figure 55 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $5500.00
  • $6600.00
  • $7920.00
  • $9504.00
  • ADD TO BASKET
  • BUY NOW